.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Citi
Dow
Baxter
McKesson
Daiichi Sankyo
Novartis
AstraZeneca
Fuji

Generated: September 22, 2017

DrugPatentWatch Database Preview

CORLANOR Drug Profile

« Back to Dashboard

What is the patent landscape for Corlanor, and what generic Corlanor alternatives are available?

Corlanor is a drug marketed by Amgen Inc and is included in one NDA. There are four patents protecting this drug.

This drug has ninety-one patent family members in forty-one countries.

The generic ingredient in CORLANOR is ivabradine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ivabradine hydrochloride profile page.

Summary for Tradename: CORLANOR

Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list22
Clinical Trials: see list2
Patent Applications: see list72
Drug Prices:see details
DailyMed Link:CORLANOR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-001Apr 15, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Amgen Inc
CORLANOR
ivabradine hydrochloride
TABLET;ORAL206143-002Apr 15, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CORLANOR

Country Document Number Estimated Expiration
TaiwanI314144► Subscribe
France2882553► Subscribe
BrazilPI0600623► Subscribe
Singapore125229► Subscribe
Israel173957► Subscribe
Singapore125228► Subscribe
Cuba20060037► Subscribe
Ukraine86595► Subscribe
Japan2006241154► Subscribe
Eurasian Patent Organization200600322► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Healthtrust
US Army
Accenture
Fuji
McKesson
Julphar
Moodys
Cantor Fitzgerald
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot